Published in Drug Week, July 30th, 2004
The new NCD formulation is a line extension of Par's currently marketed megestrol acetate oral suspension.
Megestrol acetate oral suspension NCD represents an advanced formulation of megestrol acetate oral suspension that utilizes NanoCrystal Dispersion technology to improve the bioavailablity of the drug, compared to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.